Allspring Global Investments’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Allspring Global Investments’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,290	Closed	-$127K	–	2921
2023 Q1	$127K	Buy	5,290 +3,574	+208%	+$44.9K	﹤0.01%	1954
2022 Q4	$18.1K	Buy	+1,716	New	+$13.8K	﹤0.01%	2608

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Allspring Global Investments's PRVB Position: Q2 2023 in Review

Allspring Global Investments sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 5,290 shares — an estimated $127K sold.

Allspring Global Investments first reported a position in PRVB in Q4 2022 and held it in 2 quarters. The position peaked at $127K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Allspring Global Investments reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Allspring Global Investments sold 5,290 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $127K.
Allspring Global Investments first reported a position in Provention Bio, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Allspring Global Investments's Provention Bio, Inc. Common Stock position peaked at $127K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Allspring Global Investments's 13F filing for Q2 2023, filed 18 Jul 2023.